Table of contents
If you were exposed to the herbicide dimethyl tetrachloroterephthalate (DCPA), commonly known as Dacthal, while pregnant, and your child has subsequently experienced health issues, you may be entitled to compensation. Mounting evidence points to the harmful effects of DCPA on pregnant individuals and their unborn children, leading to significant legal actions and increased regulatory oversight.
Nguyen Injury Lawyer is currently accepting new Dacthal cases for families impacted by DCPA exposure. We are dedicated to helping you pursue justice and navigate the complexities of pesticide litigation. The legal process can be overwhelming, but with the appropriate support, you can fight for the compensation and justice you deserve.
If you believe you may have a viable Dacthal lawsuit, call us today at XXX-XXX-XXXX or contact us online.
Dacthal and Its History
Dacthal, also known scientifically as dimethyl tetrachloroterephthalate (DCPA), has been around for more than six decades. First registered for use in the United States in 1958, it was primarily developed as a pre-emergent herbicide to control weed growth by preventing weed seed germination. The introduction of Dacthal was considered a major advancement in agriculture, providing farmers with an effective tool for managing weeds without harming their crops.
In its early years, Dacthal was widely used in both agricultural and non-agricultural settings. Farmers and landscapers applied it to various crops, including strawberries, peaches, broccoli, and cauliflower, as well as turf grasses on lawns and golf courses. Its ability to prevent weed seeds from germinating made it a popular choice for those seeking to maintain pristine and productive fields and lawns.
However, as Dacthal use increased, so did concerns regarding its safety and environmental impact. By the 1980s, research began to suggest that Dacthal could persist in the environment and potentially contaminate groundwater. Its breakdown products, particularly tetrachloroterephthalic acid, were found in various environmental samples, raising concerns about the long-term effects of its widespread use.
These environmental concerns led to increased scrutiny from regulatory agencies. The United States Environmental Protection Agency (EPA) began re-evaluating Dacthal’s safety, particularly its potential as a carcinogen and its impact on non-target species and water sources. By the mid-1990s, Dacthal use was restricted in several states, especially those with sensitive ecosystems where the risk of groundwater contamination was high.
Recent Developments and EPA Actions on Dacthal
In April 2024, the EPA issued a warning to farmworkers regarding the potential dangers of Dacthal, as it prepared to take further measures to mitigate these risks. This warning signaled the start of a series of regulatory actions aimed at curbing DCPA use due to its harmful effects.
The EPA highlighted significant health risks for pregnant individuals and their unborn children who come into contact with Dacthal. This herbicide is used to manage weed growth in both farming and non-farming environments, and its widespread application has made it a common source of exposure for many.
Additionally, the EPA sent a formal notification to AMVAC, the sole producer of Dacthal, outlining the identified risks and the agency’s intent to take further regulatory action. This notification clearly indicated that the EPA was taking the potential dangers of DCPA seriously and was prepared to take decisive action to protect public health.
Ban on All Use of Dacthal in August 2024
Ultimately, the EPA determined that sufficient action was needed. On August 6, 2024, the EPA issued an emergency suspension of all DCPA uses. This drastic action, the first of its kind in decades, reflects growing concerns about the herbicide’s safety, particularly regarding its impact on pregnant individuals and their unborn children.
This decision, which was scheduled to appear in Wednesday’s Federal Register under a Federal Insecticide, Fungicide, and Rodenticide Act emergency order, addresses the serious risks posed to fetuses, potentially causing thyroid issues and a host of other severe health problems.
The suspension highlights the potential for birth defects and neurological problems associated with Dacthal exposure, which are likely to lead to numerous Dacthal lawsuits in the coming years.
Michal Freedhoff, the Assistant Administrator for the EPA’s Office of Chemical Safety and Pollution Prevention, emphasized the grave nature of the threat posed by DCPA, stating it should be “removed from the market immediately.” The concern extends beyond potential food and water contamination to include risks to workers who handle this chemical.
“The EPA has a fundamental duty to safeguard individuals from harmful chemical exposures,” Freedhoff explained in a Tuesday statement. “This action is crucial because pregnant women unknowingly exposed to DCPA could have children who suffer permanent and severe health issues. This is the first time in nearly four decades that the EPA has activated its emergency suspension powers to halt a pesticide’s use.”
Despite efforts by AMVAC Chemical Corp., the sole registrant of DCPA products, to mitigate these risks, the EPA concluded that no feasible safety measures exist that would allow DCPA to continue being used without posing an imminent danger.
Where Dacthal Was Used
The states most notably at issue with Dacthal exposure are those with significant agricultural activities where Dacthal has been applied. These states typically have high concentrations of farms that grow the types of crops most often treated with Dacthal, such as broccoli, Brussels sprouts, cabbage, and onions. This includes California, Arizona, Colorado, Wisconsin, Michigan, Ohio, Oregon, Texas, and Washington. Each of these states has reported substantial use of Dacthal, so that is where we expect to see the most cases.
California: Known for its vast and diverse agricultural sector, California tops the list for Dacthal usage, particularly in counties with high production of vegetables like Monterey, Imperial, and Fresno. The state’s extensive farming operations contribute to the heightened risk of DCPA exposure to workers and residents.
Arizona and Texas: These states have significant agricultural outputs and use Dacthal in various capacities, often in vegetable production that includes crops like cabbage and onions, which are prevalent in these regions.
Oregon and Washington: With robust agricultural sectors, especially in areas where specialty crops are grown, these states see substantial Dacthal application. This includes not only farmworkers but also those in adjacent communities who might be exposed through environmental contamination.
Michigan and Ohio: These states have specific regions where Dacthal use has been documented, particularly in areas focused on vegetable production. The localized use affects those directly involved with agricultural processes and nearby populations.
Wisconsin and Colorado: Similar to other states, the use of Dacthal in these areas is primarily due to crop cultivation that requires the application of this herbicide, posing risks to those directly involved in its application and those living in proximity to treated fields.
These states are often highlighted in litigation and regulatory discussions due to the prevalence of Dacthal use and the potential risks to pregnant farmworkers and local communities, leading to health concerns that include changes to fetal thyroid hormone levels and other developmental issues in newborns.
What Type of Dacthal Lawsuits Are We Accepting?
Nguyen Injury Lawyer is advocating for the rights of individuals and families adversely affected by this hazardous pesticide. We are focusing on specific criteria for these cases to ensure that each client receives the highest level of legal support.
You may be eligible for compensation if:
- You worked on a farm or nursery where DCPA-treated crops were grown during your pregnancy.
- You were exposed to DCPA through direct application or proximity to treated areas.
- Your child has experienced health issues that may be linked to DCPA exposure.
Our Dacthal lawyers are looking for victims who had direct exposure. Could you be harmed from indirect exposure? Absolutely. But, at this stage, our attorneys do not think these cases can be proved. So claimants must demonstrate that they had direct exposure to Dacthal for Nguyen Injury Lawyer to get involved. This typically will involve providing evidence that you were either working in or residing near locations where Dacthal was actively used, such as on farms, in nurseries, or in residential landscaping areas.
The strongest DCPA lawsuits that will garner the highest settlement amounts and jury payouts are cases where there is significant duration and intensity of the exposure.
Is Birth Defect the Only Injury from Dacthal?
Right now, birth defects and developmental delays in children as a result of the mother’s exposure to DCPA are the primary focus of this litigation. Experts have been saying for years that DCPA poses significant risks to unborn fetuses, leading to neurodevelopmental issues, low birth weight, and decreased IQ. Despite AMVAC’s claims that fields treated with Dacthal are safe after 12 hours, the EPA found that unsafe levels of the pesticide could persist for up to 25 days, posing risks not only to workers but also to nearby communities due to pesticide drift.
But while birth defects and developmental delays are the signature injury in these cases, the science is rapidly evolving, and our attorneys anticipate that lawsuits related to Dacthal exposure may also include claims for various types of cancer and thyroid disorders.
Our DCPA attorneys will work closely with your doctors and other medical experts to establish a link between your injuries and Dacthal exposure. The injuries associated with this pesticide are not fully understood at this point, and ongoing research is crucial to building strong cases.
Projected Trial Outcomes and Settlement Values of DCPA Lawsuits
The litigation involving Dacthal is still in its early stages, and many questions remain unanswered. We do not yet know the full scope of these lawsuits, nor do we know if there will be a class action lawsuit involving Dacthal. However, there is a well-established history of settlement amounts and jury payouts in similar cases that we can use to predict potential trial outcomes and settlement figures.
The expectation is that the primary focus of the Dacthal litigation will be the health risks posed by the chemical, particularly to pregnant individuals and their unborn children.
The outcomes of DCPA trials will heavily depend on the presentation of scientific evidence linking Dacthal exposure to specific health issues such as thyroid dysfunction, developmental delays, and other congenital disabilities. The strength of individual cases will vary based on the ability to directly connect health problems with DCPA exposure, the credibility of expert witnesses, and the specific circumstances of exposure.
Proving causation in chemical exposure cases is always challenging. However, if plaintiffs successfully demonstrate that DCPA exposure led to these injuries, juries could award significant damages, especially if there is evidence that the manufacturer, AMVAC Chemical Corp., failed to provide adequate warnings or, even more powerfully, knowingly concealed risks. Such findings could lead to substantial punitive damages awards.
What Will Drive Dacthal Lawsuit Settlement Compensation?
Settlement values in DCPA lawsuits could be influenced by several factors:
Severity of Harm: Settlement amounts will likely scale with the severity of the harm suffered. Cases involving severe, lifelong disabilities or conditions requiring extensive medical treatment will command higher settlements.
Number of Plaintiffs
Potential Class Action or Multidistrict Litigation
The progression of individual lawsuits into a class action or multidistrict litigation (MDL) could significantly alter the course of litigation. Bringing together a large group of plaintiffs might lead to a comprehensive settlement offer, which would then be allocated among the plaintiffs based on factors such as the severity of their conditions, the extent of their exposure to Dacthal, and other relevant considerations.
The Developing Science
Our attorneys at Nguyen Injury Lawyer anticipate substantial evidence will emerge demonstrating that Dacthal can cause birth defects. The EPA’s decision to remove Dacthal from the market highlights the serious nature of the risks involved. However, the strength of the scientific evidence and the ability to definitively prove that a child’s birth defects were a direct result of the mother’s exposure remain to be seen.
Precedent and Public Sentiment
Following the EPA’s emergency ban, public and regulatory pressure may encourage AMVAC to pursue settlements in order to manage their public image and mitigate legal risks. The outcomes of initial trials could also influence settlement decisions, setting precedents for compensation amounts.
Company Knowledge
Internal documents held by AMVAC will be crucial in determining the outcomes of these lawsuits. Evidence suggesting that AMVAC was aware of the risks associated with DCPA and deliberately concealed this information could lead to significant verdicts and punitive damages, substantially increasing potential settlement amounts.
Insurance Coverage
AMVAC has a reported net worth of $146 million, which may not be sufficient to cover all potential liabilities. It is hoped and expected that the company has adequate insurance coverage to handle settlements and verdicts.
Projected Settlement Compensation
While specific figures remain speculative at this early stage, settlements could range from moderate amounts for less severe cases to multi-million-dollar payouts for cases involving significant disabilities or lifelong health issues. The settlement process will likely involve a detailed assessment of each individual claim, with adjustments based on the collective outcomes of ongoing and future trials.
As these cases develop, it will be essential to closely monitor the evolving legal landscape and emerging scientific evidence to accurately predict the trajectory of DCPA litigation and potential settlement outcomes. Serious birth defect cases could potentially see compensation in the millions, a likely scenario according to our lawyers.
Contact Nguyen Injury Lawyer for Your Dacthal Case
If you or someone you know was exposed to Dacthal during pregnancy and has experienced adverse health outcomes, Nguyen Injury Lawyer is here to offer the support and guidance you need. We are committed to helping you navigate this complex legal process and secure the compensation you deserve.
Contact Nguyen Injury Lawyer today at XXX-XXX-XXXX or through our free online consultation form.